FODMAP

This month’s cover story focuses on the integrated, team-based approach to managing patients with irritable bowel syndrome.

A short-term, moderately low FODMAP diet, in addition to a strict gluten-free diet, significantly reduced gastrointestinal symptoms and improved disease-specific health in celiac patients, according to a study.

Healio Gastroenterology presents the following report on the top stories from UEG Week 2021.

Utilization of low FODMAP powders aided in control of symptom severity, somatization and depression for patients with irritable bowel syndrome in a tertiary care setting, according to findings presented at the UEG Week Virtual 2021.

A low FODMAP diet improved predominant meal-related postprandial distress syndrome symptoms among patients with functional dyspepsia, according to a presentation at UEG Week Virtual.

Patients with irritable bowel syndrome had improved symptom severity and normalized gut microbiota while following a low-FODMAP diet combined with a gluten-free diet, according to data published in BMC Gastroenterology.

Patients with irritable bowel syndrome who engaged in severe food avoidance and restriction experienced more severe IBS symptoms and a reduced quality of life, according to study results.

A FODMAP-lowering diet administered through smartphone application was superior to standard medical therapy alone in improved symptom severity among patients with irritable bowel syndrome, according to a presentation at Digestive Disease Week.

A low-FODMAP diet tailored for short- or long-term use improved symptoms of irritable bowel syndrome-diarrhea, according to a recent study. It was the top story in gastroenterology last week.

A short-term strict low FODMAP diet and long-term ‘modified’ low FODMAP diet was linked to improvements in symptoms and quality of life in irritable bowel syndrome-diarrhea predominant patients, according to study results.